Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001554795-17-000099
Filing Date
2017-03-20
Accepted
2017-03-17 18:05:11
Documents
41
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K skin0314form10k.htm 10-K 254592
2 EXHIBIT 3.1 skin0314form10kexh3i.htm EX-3.1 22419
3 EXHIBIT 3.2 skin0314form10kexh3ii.htm EX-3.2 79161
4 EXHIBIT 31.1 skin0314form10kexh31_1.htm EX-31.1 8242
5 EXHIBIT 31.2 skin0314form10kexh31_2.htm EX-31.2 8275
6 EXHIBIT 32.1 skin0314form10kexh32_1.htm EX-32.1 4379
  Complete submission text file 0001554795-17-000099.txt   1116790

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE skin-20161231.xml EX-101.INS 81238
8 XBRL SCHEMA FILE skin-20161231.xsd EX-101.SCH 12820
9 XBRL CALCULATION FILE skin-20161231_cal.xml EX-101.CAL 22377
10 XBRL DEFINITION FILE skin-20161231_def.xml EX-101.DEF 14456
11 XBRL LABEL FILE skin-20161231_lab.xml EX-101.LAB 89538
12 XBRL PRESENTATION FILE skin-20161231_pre.xml EX-101.PRE 70141
Mailing Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106 8013232395
SKINOVATION PHARMACEUTICAL INC (Filer) CIK: 0001118072 (see all company filings)

EIN.: 870458170 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30991 | Film No.: 17699392
SIC: 6770 Blank Checks